Endexx Corporation Announces Strategic Shift in Auditor Services to Bolster Growth and Transparency
February 16, 2024
Drug Manufacturers
-
-
Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider
February 14, 2024
-
City Trees Production Facility Achieves Unprecedented Milestone with Record-Breaking Sales Month
February 6, 2024
-
Curaleaf International Acquires Can4Med, Expanding Presence in Poland’s Growing Medical Cannabis Market
February 6, 2024
-
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
February 1, 2024
-
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
January 18, 2024
-
22nd Century Group Provides Shareholder Update and Highlights Insider Stock Purchases from Management
January 17, 2024
-
Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
January 17, 2024
-
Curaleaf Expands Zero Proof(TM) Brand Portfolio with Launch of Stir Fast-Acting THC Beverage Mix
January 8, 2024
-
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
December 27, 2023
-
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
December 20, 2023
-
Cosmos Health Announces Open Market Stock Purchases by the CEO
December 18, 2023
-
Curaleaf Begins Adult Use Wholesale Operations in New York
December 12, 2023
-
Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Provider
December 12, 2023
-
Red White & Bloom Provides Update Relating to Aleafia Health
November 22, 2023
-
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders’ Equity of $44.2M or $3.4/Share
November 21, 2023